Frailty and sarcopenia

From theory to clinical implementation and public health relevance

Matteo Cesari, Alessandro Nobili, Giovanni Vitale

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

The sustainability of healthcare systems is threatened by the increasing (absolute and relative) number of older persons referring to clinical services. Such global phenomenon is questioning the traditional paradigms of medicine, pushing towards the need of new criteria at the basis of clinical decision algorithms. In this context, frailty has been advocated as a geriatric condition potentially capable of overcoming the weakness of chronological age in the identification of individuals requiring adapted care due to their increased vulnerability to stressors. Interestingly, frailty poses itself beyond the concept of nosological conditions due to the difficulties at correctly framing traditional diseases in the complex and heterogeneous scenario of elders. Thus, frailty may play a key role in public health policies for promoting integrated care towards biologically aged individuals, currently presenting multiple unmet clinical needs. At the same time, the term frailty has also been frequently used in the literature for framing a physical condition of risk for (mainly functional) negative endpoints. The combination of such physical impairment with an organ-specific phenotype (e.g., the age-related skeletal muscle decline or sarcopenia) may determine the assumptions for the development of a clinical condition to be used as potential target for ad hoc interventions against physical disability. In the present article, we present the background of frailty and sarcopenia, and discuss their potentialities for reshaping current clinical and research practice in order to promote holistic approach to older patients, solicit personalization of care, and develop new targets for innovative interventions.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalEuropean Journal of Internal Medicine
Volume35
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Sarcopenia
Public Health
Traditional Medicine
Public Policy
Health Policy
Geriatrics
Skeletal Muscle
Delivery of Health Care
Phenotype
Research

Keywords

  • Ageing
  • Elderly
  • Geriatrics
  • Preventive medicine
  • Skeletal muscle

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Frailty and sarcopenia : From theory to clinical implementation and public health relevance. / Cesari, Matteo; Nobili, Alessandro; Vitale, Giovanni.

In: European Journal of Internal Medicine, Vol. 35, 01.11.2016, p. 1-9.

Research output: Contribution to journalReview article

@article{5d12ff93f989453592e6be896cbe3c10,
title = "Frailty and sarcopenia: From theory to clinical implementation and public health relevance",
abstract = "The sustainability of healthcare systems is threatened by the increasing (absolute and relative) number of older persons referring to clinical services. Such global phenomenon is questioning the traditional paradigms of medicine, pushing towards the need of new criteria at the basis of clinical decision algorithms. In this context, frailty has been advocated as a geriatric condition potentially capable of overcoming the weakness of chronological age in the identification of individuals requiring adapted care due to their increased vulnerability to stressors. Interestingly, frailty poses itself beyond the concept of nosological conditions due to the difficulties at correctly framing traditional diseases in the complex and heterogeneous scenario of elders. Thus, frailty may play a key role in public health policies for promoting integrated care towards biologically aged individuals, currently presenting multiple unmet clinical needs. At the same time, the term frailty has also been frequently used in the literature for framing a physical condition of risk for (mainly functional) negative endpoints. The combination of such physical impairment with an organ-specific phenotype (e.g., the age-related skeletal muscle decline or sarcopenia) may determine the assumptions for the development of a clinical condition to be used as potential target for ad hoc interventions against physical disability. In the present article, we present the background of frailty and sarcopenia, and discuss their potentialities for reshaping current clinical and research practice in order to promote holistic approach to older patients, solicit personalization of care, and develop new targets for innovative interventions.",
keywords = "Ageing, Elderly, Geriatrics, Preventive medicine, Skeletal muscle",
author = "Matteo Cesari and Alessandro Nobili and Giovanni Vitale",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.ejim.2016.07.021",
language = "English",
volume = "35",
pages = "1--9",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Frailty and sarcopenia

T2 - From theory to clinical implementation and public health relevance

AU - Cesari, Matteo

AU - Nobili, Alessandro

AU - Vitale, Giovanni

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The sustainability of healthcare systems is threatened by the increasing (absolute and relative) number of older persons referring to clinical services. Such global phenomenon is questioning the traditional paradigms of medicine, pushing towards the need of new criteria at the basis of clinical decision algorithms. In this context, frailty has been advocated as a geriatric condition potentially capable of overcoming the weakness of chronological age in the identification of individuals requiring adapted care due to their increased vulnerability to stressors. Interestingly, frailty poses itself beyond the concept of nosological conditions due to the difficulties at correctly framing traditional diseases in the complex and heterogeneous scenario of elders. Thus, frailty may play a key role in public health policies for promoting integrated care towards biologically aged individuals, currently presenting multiple unmet clinical needs. At the same time, the term frailty has also been frequently used in the literature for framing a physical condition of risk for (mainly functional) negative endpoints. The combination of such physical impairment with an organ-specific phenotype (e.g., the age-related skeletal muscle decline or sarcopenia) may determine the assumptions for the development of a clinical condition to be used as potential target for ad hoc interventions against physical disability. In the present article, we present the background of frailty and sarcopenia, and discuss their potentialities for reshaping current clinical and research practice in order to promote holistic approach to older patients, solicit personalization of care, and develop new targets for innovative interventions.

AB - The sustainability of healthcare systems is threatened by the increasing (absolute and relative) number of older persons referring to clinical services. Such global phenomenon is questioning the traditional paradigms of medicine, pushing towards the need of new criteria at the basis of clinical decision algorithms. In this context, frailty has been advocated as a geriatric condition potentially capable of overcoming the weakness of chronological age in the identification of individuals requiring adapted care due to their increased vulnerability to stressors. Interestingly, frailty poses itself beyond the concept of nosological conditions due to the difficulties at correctly framing traditional diseases in the complex and heterogeneous scenario of elders. Thus, frailty may play a key role in public health policies for promoting integrated care towards biologically aged individuals, currently presenting multiple unmet clinical needs. At the same time, the term frailty has also been frequently used in the literature for framing a physical condition of risk for (mainly functional) negative endpoints. The combination of such physical impairment with an organ-specific phenotype (e.g., the age-related skeletal muscle decline or sarcopenia) may determine the assumptions for the development of a clinical condition to be used as potential target for ad hoc interventions against physical disability. In the present article, we present the background of frailty and sarcopenia, and discuss their potentialities for reshaping current clinical and research practice in order to promote holistic approach to older patients, solicit personalization of care, and develop new targets for innovative interventions.

KW - Ageing

KW - Elderly

KW - Geriatrics

KW - Preventive medicine

KW - Skeletal muscle

UR - http://www.scopus.com/inward/record.url?scp=84997107241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997107241&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2016.07.021

DO - 10.1016/j.ejim.2016.07.021

M3 - Review article

VL - 35

SP - 1

EP - 9

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

ER -